文献速递乳腺癌放疗放疗物理与技术

范可尼贫血合并乳腺癌患者放疗可行性:一例报告与文献综述

Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature.
PubMed 文献 · Clin Transl Radiat Oncol · 2021-04-09

本文报告一例范可尼贫血(FA)患者先后发生双侧乳腺肿瘤:首诊为浸润性乳腺癌,接受保乳治疗且未出现明显治疗相关毒性;对侧乳腺后续诊断为高级别导管原位癌,经手术及精心规划的辅助放疗成功管理,治疗无中断。文章结合文献综述探讨FA患者乳腺癌放疗的可行性与复杂性。

要点

  • 范可尼贫血患者对放疗和全身治疗存在超敏反应,肿瘤治疗需个体化规划。
  • 本例FA患者保乳治疗后未出现明显治疗相关毒性。
  • 对侧高级别导管原位癌经手术加精心规划辅助放疗,治疗无中断。

核心结论

  • 范可尼贫血合并乳腺癌患者经精心规划的放疗可行,本病例未出现明显治疗相关毒性且治疗无中断。

研究设计与样本

  • 个案报告结合文献综述,报告一例范可尼贫血患者的乳腺癌诊治经过。

主要发现

  • 患者首诊为浸润性乳腺癌,接受保乳治疗,未出现明显治疗相关毒性。
  • 对侧乳腺后续诊断为高级别导管原位癌,经手术和精心规划的辅助放疗成功管理,治疗无中断。

临床怎么用

  • 范可尼贫血患者的乳腺癌放疗需多学科协作并精心规划,以平衡肿瘤控制与治疗毒性风险。

局限性

  • 本文为单例个案报告,结论的普遍适用性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fanconi Anemia (FA) is a rare inherited autosomal recessive disease that results in impaired double stranded DNA repair. This leads to both increased susceptibility to various cancers, as well as hypersensitivity to radiotherapy and systemic therapy; thus, increasing the complexity of oncological treatment paradigm. Here, we present an FA patient who initially developed invasive breast cancer for which she received breast conserving treatment with no significant treatment related toxicity. This was followed by a diagnosis of high-grade ductal carcinoma-in-situ in the contralateral breast, which was managed successfully by surgery and meticulously planned adjuvant radiotherapy, with no treatment interruptions.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Hafeez N, Musunuru HB, Keller A, et al. Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature. Clin Transl Radiat Oncol. 2021. PMID: 33981866. doi:10.1016/j.ctro.2021.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。